•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A09156 Summary:

BILL NOA09156B
 
SAME ASSAME AS S08925-A
 
SPONSORSteck
 
COSPNSRWalsh, Griffin, Hevesi, Buttenschon, Simon, Glick, Hyndman, Ra, McDonald, Novakhov, Simpson, Brook-Krasny, Durso, Woerner, Blumencranz, Otis
 
MLTSPNSR
 
Add §392-l, Gen Bus L
 
Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
Go to top    

A09156 Actions:

BILL NOA09156B
 
10/17/2025referred to consumer affairs and protection
01/07/2026referred to consumer affairs and protection
01/09/2026amend and recommit to consumer affairs and protection
01/09/2026print number 9156a
05/08/2026amend and recommit to consumer affairs and protection
05/08/2026print number 9156b
05/11/2026reported referred to codes
05/28/2026reported referred to ways and means
06/03/2026reported referred to rules
06/03/2026reported
06/03/2026rules report cal.408
06/03/2026ordered to third reading rules cal.408
06/03/2026substituted by s8925a
 S08925 AMEND=A RYAN C
 01/16/2026REFERRED TO CONSUMER PROTECTION
 05/11/2026AMEND AND RECOMMIT TO CONSUMER PROTECTION
 05/11/2026PRINT NUMBER 8925A
 05/20/20261ST REPORT CAL.1297
 05/21/20262ND REPORT CAL.
 05/26/2026ADVANCED TO THIRD READING
 06/02/2026PASSED SENATE
 06/02/2026DELIVERED TO ASSEMBLY
 06/02/2026referred to ways and means
 06/03/2026substituted for a9156b
 06/03/2026ordered to third reading rules cal.408
 06/05/2026passed assembly
 06/05/2026returned to senate
Go to top

A09156 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A9156B
 
SPONSOR: Steck
  TITLE OF BILL: An act to amend the general business law, in relation to prohibiting the sale of 7-hydroxymitragynine products   SUMMARY OF SPECIFIC PROVISIONS: Section 1 clarifies the definition of "7-hydroxymitragynine products" as any finished good that contains 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or 1 mg per serving. This section further states that any business entity that knowingly violates the provisions of this section will be subject to a civil penalty of not more than five hundred dollars for a first violation, and one thousand dollars for each following violation. All capital gained from the civil penalties will be deposited in the New York State Drug Treatment and Public Education Fund. Section 2 states that this act will take effect on the ninetieth day after it shall become a law.   PURPOSE AND JUSTIFICATION: In July of 2025, the FDA implemented warnings over the recent sale and usage of 7hydroxymitragynine products (7-OH) derived from Kratom, an herbal substance originating from Southeast Asia'. 7-OH is a concen- tration that acts as an opioid, providing effects like pain relief, mood enhancement, and sedation. While 100% natural Kratom products contain 7-OH at levels that are less than or equal to 2% of total alkaloids, synthetic products that can be purchased at gas stations and smoke shops that have much higher levels of 7-0H2. 7-OH is approximately 13 times more potent than morphine, making it one of the most powerful naturally occurring opioid-like compounds. As such, 7-OH has been abused for its properties with side effects includ- ing addiction, anxiety, depression, seizures, and severe withdrawal. Due to almost no regulation and easy access for consumers, 7-OH products have become widespread throughout New York State, increasing addiction rates and threatening the residents of New York. To address this issue, this legislation would ban the sale and distrib- ution of 7-OH products. All business entities found to be knowingly selling 7-OH products will be subject to a civil penalty of not more than $500 for a first violation and $1,000 for each subsequent violation. The civil penalties will be deposited into the New York State Drug Treatment and Public Education Fund. Alabama, Arkansas, Colorado, Indiana, Mississippi, Vermont and Wisconsin all have passed legislation that would ban the sale of 7-053. On September 22nd, Dr. Michael White, a department head at the University of Connecticut School of Pharmacy and chair of the Kratom Consumer Advisory Council, recommended that New York State take this action during an episode of the Capitol Pressroom. 4   LEGISLATIVE HISTORY: New Legislation   FISCAL IMPLICATIONS: The civil penalties will be deposited into the New York State Drug Treatment and Public Education Fund.   EFFECTIVE DATE: This act shall take effect on the ninetieth day after it becomes law. 1 https://www.press-announcements/fda-takes-steps- restrict-7-oh-o- pioid-productsthreatening- american-consumers 2 https://www.fda.gov/meclia/187899/download?attachment 3 https://www.rockinst.org/blogion-kratom-or- the-fractured-regulatio- nof-u nscheduied-drugs/ 4 https://soundcloud.com/user-1893/09-22-25 c*se*5 web
Go to top

A09156 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         9156--B
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                    October 17, 2025
                                       ___________
 
        Introduced  by  M.  of  A.  STECK,  WALSH, GRIFFIN, HEVESI, BUTTENSCHON,
          SIMON, GLICK, HYNDMAN, RA, McDONALD, NOVAKHOV, SIMPSON,  BROOK-KRASNY,
          DURSO  --  read once and referred to the Committee on Consumer Affairs
          and Protection -- recommitted to the Committee on Consumer Affairs and
          Protection in accordance with Assembly Rule 3,  sec.  2  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to  said  committee  -- again reported from said committee with amend-
          ments, ordered reprinted as amended and recommitted to said committee
 
        AN ACT to amend the general business law, in relation to prohibiting the
          sale of 7-hydroxymitragynine products
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. The general business law is amended by adding a new section
     2  392-l to read as follows:
     3    §  392-l.  Sale  of  7-hydroxymitragynine products. 1. For purposes of
     4  this section, the term "7-hydroxymitragynine products"  shall  mean  any
     5  substance,   material,   mixture,  compound,  preparation,  extract,  or
     6  finished goods  that  contains  7-hydroxymitragynine  at  a  level  that
     7  exceeds two percent of total alkaloids or one milligram per serving.
     8    2.  The  provisions of this section shall apply to the sale, offer for
     9  sale, delivery, or distribution of all 7-hydroxymitragynine products.
    10    3. No  corporation,  partnership,  limited  liability  company,  firm,
    11  online platform, or any other business entity doing business within this
    12  state shall knowingly sell, offer for sale, or deliver 7-hydroxymitragy-
    13  nine products.
    14    4.  Any  corporation,  partnership,  limited  liability company, firm,
    15  online platform, or other business entity  doing  business  within  this
    16  state that violates the provisions of this section by knowingly selling,
    17  offering  for sale, or delivering 7-hydroxymitragynine products shall be
    18  subject to a civil penalty of not more than five hundred dollars  for  a
    19  first violation, and one thousand dollars for each subsequent violation,
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13840-04-6

        A. 9156--B                          2
 
     1  recoverable  in  an  action  by the attorney general of the state of New
     2  York. All funds collected or received by the state from civil  penalties
     3  imposed under this section shall be deposited in the New York state drug
     4  treatment  and  public  education  fund  established pursuant to section
     5  ninety-nine-jj of the state finance law.
     6    § 2. This act shall take effect on the ninetieth day  after  it  shall
     7  have become a law.
Go to top